In North America, the incidence of skin cancer has increased in recent decades. This may be partly due to factors such as increased exposure to ultraviolet light from outdoor activities and sunburns, and an aging population. Therefore, the demand for treatment is increasing such as targeted therapies and immunotherapies. The development of new and innovative treatments for skin cancer which show promise in treating advanced melanoma and other types of skin cancer and may become more widely available in the future.
Further,theNorth America Skin Cancer Dermatology Marketis expected to grow at a strong CAGR of 6.0% during the forecast period (2022-2028).U.S. is anticipated to dominate North America skin cancer dermatology market primarily owing to the spur in demand for skin cancer screening and prevention services. Moreover, the aging population is more susceptible to skin cancer due to a lifetime of UV exposure. As the United States ages, more than one in six Americans is now 65 or older, the demand of skin cancer therapeutics is expected to increase in future also.For Instance, according to the 2020 report by Administration on Aging, about 17% of people living in the United States.
Request for Sample PDF-https://univdatos.com/report/north-america-skin-cancer-dermatology-market/get-a-free-sample-form.php?product_id=37722
FIG. 1 North America Skin Cancer Dermatology Market Revenue (2020-2028) USD Mn
For a detailed analysis of the Global North America skin cancer dermatology Market browse throughhttps://univdatos.com/report/north-america-skin-cancer-dermatology-market/
Based on test type, the North America skin cancer dermatology market is segmented into skin biopsy and diagnostic imaging. In our estimation, diagnostic imaging is expected to grow with a significant CAGR during the forecast period. This is mainly due to the launches of improved non-invasive techniques, such as high-frequency ultrasound, magnetic resonance imaging, and laser scanning confocal microscopy. However, the high adoption of these techniques increases the demand for diagnostic imaging.
By age group, the market is segmented into 0-19, 20-39, 40-64, 65-84, and 85 and above. As per our analysis, the 40-64 segment is expected to grow with a significant CAGR during the forecast period. This is mainly attributed to prolonged sun exposure with the rising rate of new melanomas of skin cancer by age group that cause high demand for tanning kit among the population.
Ask for Customization @ https://univdatos.com/report/north-america-skin-cancer-dermatology-market/get-a-free-sample-form.php?product_id=37722
Global North America Skin Cancer Dermatology Market Segmentation
Market Insight, by Test Type
Skin Biopsy
Diagnostic Imaging
Market Insights, by Facility Type
Hospital Outpatient Departments
Stand-alone Practices
Multispecialty Clinics
Market Insights, by Age Group
0-19
20-39
40-64
65-84
85 and above
Market Insight, by Country
U.S.
Canada
Rest of North America
Top Company Profiles
Speclipse, Inc.
Agilent Technologies, Inc.
MetaOptima Technology Inc.
FotoFinder Systems, Inc
Canfield Scientific, Inc.
SkinIO, Inc.
Firefly Health, Inc.
DermLite
Eli Lilly and Company
Bristol-Myers Squibb Company
